NEW YORK, Aug. 2, 2023 /PRNewswire/ — The 3D bioprinting market size is estimated to grow by USD 2,015.81 million from 2022 to 2027, growing at a CAGR of 19.94%. North America is estimated to account for 31% of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In 2022, North America accounted for the largest revenue share of the global 3D bioprinting market. In North America, the US and Canada are the significant revenue contributors to the market in focus. Moreover, the growth of the market in focus in the region can be attributed to enhanced healthcare infrastructure, high adoption of 3D bioprinting technologies in healthcare facilities, and the presence of established companies. For Comprehensive details on the market size of historic period(2017 to 2021) and forecast period (2023-2027) – View the Sample report

Key Developments:

• Rapid advances in technology, intense competition, and changing dynamics in the market are the key factors for the intense competition among vendors. 
• With the rising competition, the market will see consolidation. However, manufacturing complexities and high production costs pose significant risk factors for vendors in the market.

Market Dynamics

Major Drivers & Challenges

The advancements in 3D bioprinting technology are notably driving the 3D bioprinting market growth. The 3D bioprinting market is being significantly fueled by the continued progress in 3D bioprinting technologies, such as better bio-ink formulations, printing methods, and tissue engineering strategies. Such advancements permit the creation of more complex and functional tissue structures, which will change the field of regeneration medicine. The new formulations of bio-inks enhance cell survival, promote tissue fusion and make it more comfortable to construct structures that are personalized for each patient. Moreover, advancements in printing methods, including the use of multiple printheads or extruders, enable the simultaneous deposition of several cell types and materials, delivering more accurate and intricate tissue constructs. Moreover, creative approaches to tissue engineering, e.g., bioprinting on pre-pasteurized substrates or the application of thin fibrin networks, deliver exciting options for building strong and efficient tissues. Thus, the emergence of 3D bioprint technology is boosting market growth and driving boundaries for regenerative medicine and personalized health care by improving the likelihood that tissues or organs will be developed in accordance with both physiological and therapeutic needs. Therefore, such factors are expected to drive market growth during the forecast period. 

The inability of researchers to combine vascular supply in printed tissues and organs is a major challenge impeding market growth. Despite significant advancements in the 3D bioprinting market, the complete bioprinting of fully functional organs or tissues for transplant remains a challenge. While researchers have successfully bioprinted parts of organs or tissues with functional cells, integrating vascular veins within the printed organs remains a hurdle. Though vascular veins can be printed separately, the bioprinted product requires a vascular system and proper blood flow for optimal functionality. The current limitations on vascular integration restrict the thickness and viability of the printed tissue. Until a viable and fully intact organ is developed for transplantation, the growth of the 3D bioprinting market may be constrained. Commercial availability of this technology to end users is not anticipated in the foreseeable future, making the challenge of integrating blood vessel supply a potential hindrance to the market’s growth over the forecast period.

Key Trends

The fabrication of complex tissues is an emerging trend shaping market growth. A significant trend in the global 3D bioprinting market is the focus on fabricating complex tissues and multi-organ complexes. Researchers are exploring the simultaneous printing of various cell types, extracellular matrix, and growth hormones to create functioning tissues with intricate structures. The development of such multi-organ complexes and complex tissues has promising implications for personalized healthcare and regenerative medicine. As a result, this trend is expected to strongly influence the market’s growth over the forecast period.

Technavio has identified key trends, drivers, and challenges in the market, which will help clients improve their strategies to stay ahead of their competitors. – View Sample Report

Vendor Landscape

The 3D bioprinting market is fragmented; the vendors are competing with competitors and are trying to get greater market share. The market is growing, and the chances of new entrants cannot be overlooked. The major vendors have well-established economies of scale and market presence and generally rely on positioning technological advances, and the price of the products –The report provides a full list of key vendors, their strategies, and the latest developments. Buy Now

Company Profiles

The 3D bioprinting market report includes information on the product launches, sustainability, and prospects of leading vendors including 3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc.

Competitive Analysis

The report includes competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others.

Market Segmentation

This 3D bioprinting market report extensively covers market segmentation by application (human tissue and organ generation, medical testing, dental, prosthetics, and others), solution (3D bioprinters, bioprinting materials, and services and ancillary equipment), and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The market share growth by the human tissue and organ generation segment will be significant during the forecast period. Human tissue and organ generation through 3D bioprinting holds the potential to reduce the waiting time for patients in need of organ transplants and minimize the risk of implant rejection. While the technology is still in its developmental stage, significant progress has been made, with the successful creation of a human kidney in laboratories and research organizations. Although human trials for bioprinted organs were not ready until 2017, the demand for 3D bioprinting in this application is expected to increase and drive the growth of the market in focus during the forecast period.

Register for a trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Related Reports:

The 3D mapping and modeling market size is estimated to grow at a CAGR of 15.24% between 2022 and 2027. The 3D mapping and modeling market size is forecast to increase by USD 7,086.65 million. This report extensively covers market segmentation by component (software and services), product (3D modeling and 3D mapping), and geography (North America, APAC, Europe, Middle East and Africa, and South America). The growing use of 3D mapping and modeling in building and construction is notably driving market growth. 

The 3D imaging market share is expected to increase by USD 29.17 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 17.5%. This report extensively covers the 3D imaging market segmentation by application (healthcare, media and entertainment, industrial, defense, and others) and geography (North America, Europe, APAC, South America, and Middle East and Africa). One of the key factors driving growth in the 3D imaging market is the increasing product launches.

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Solution
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global 3D bioprinting market 2017 – 2021
• Exhibit 18: Historic Market Size – Data Table on global 3d bioprinting market 2017 – 2021 ($ million)

• 4.2 Application Segment Analysis 2017 – 2021
• Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)

• 4.3 Solution Segment Analysis 2017 – 2021
• Exhibit 20: Historic Market Size – Solution Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments 
• Exhibit 30: Chart on Application – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application – Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Human tissue and organ generation – Market size and forecast 2022-2027 
• Exhibit 34: Chart on Human tissue and organ generation – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Human tissue and organ generation – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Human tissue and organ generation – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Human tissue and organ generation – Year-over-year growth 2022-2027 (%)

• 6.4 Medical testing – Market size and forecast 2022-2027
• Exhibit 38: Chart on Medical testing – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Medical testing – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Medical testing – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Medical testing – Year-over-year growth 2022-2027 (%)

• 6.5 Dental – Market size and forecast 2022-2027
• Exhibit 42: Chart on Dental – Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Dental – Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Dental – Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Dental – Year-over-year growth 2022-2027 (%)

• 6.6 Prosthetics – Market size and forecast 2022-2027
• Exhibit 46: Chart on Prosthetics – Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Prosthetics – Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Prosthetics – Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Prosthetics – Year-over-year growth 2022-2027 (%)

• 6.7 Others – Market size and forecast 2022-2027
• Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)

• 6.8 Market opportunity by Application 
• Exhibit 54: Market opportunity by Application ($ million)
• Exhibit 55: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Solution

• 7.1 Market segments 
• Exhibit 56: Chart on Solution – Market share 2022-2027 (%)
• Exhibit 57: Data Table on Solution – Market share 2022-2027 (%)

• 7.2 Comparison by Solution 
• Exhibit 58: Chart on Comparison by Solution
• Exhibit 59: Data Table on Comparison by Solution

• 7.3 3D bioprinters – Market size and forecast 2022-2027
• Exhibit 60: Chart on 3D bioprinters – Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on 3D bioprinters – Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on 3D bioprinters – Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on 3D bioprinters – Year-over-year growth 2022-2027 (%)

• 7.4 Bioprinting materials – Market size and forecast 2022-2027 
• Exhibit 64: Chart on Bioprinting materials – Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Bioprinting materials – Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Bioprinting materials – Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Bioprinting materials – Year-over-year growth 2022-2027 (%)

• 7.5 Services and ancillary equipment – Market size and forecast 2022-2027 
• Exhibit 68: Chart on Services and ancillary equipment – Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Data Table on Services and ancillary equipment – Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Chart on Services and ancillary equipment – Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Services and ancillary equipment – Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by Solution 
• Exhibit 72: Market opportunity by Solution ($ million)
• Exhibit 73: Data Table on Market opportunity by Solution ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 75: Chart on Market share by geography 2022-2027 (%)
• Exhibit 76: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027
• Exhibit 79: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027
• Exhibit 83: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027
• Exhibit 87: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027 
• Exhibit 91: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027
• Exhibit 95: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 China – Market size and forecast 2022-2027
• Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.9 Germany – Market size and forecast 2022-2027
• Exhibit 103: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.10 Canada – Market size and forecast 2022-2027
• Exhibit 107: Chart on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Canada – Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Canada – Year-over-year growth 2022-2027 (%)

• 9.11 Japan – Market size and forecast 2022-2027
• Exhibit 111: Chart on Japan – Market size and forecast 2022-2027 ($ million)
• Exhibit 112: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
• Exhibit 113: Chart on Japan – Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on Japan – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 115: Market opportunity by geography ($ million)
• Exhibit 116: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 117: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 119: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 121: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 122: Matrix on vendor position and classification

• 12.3 3D Bioprinting Solutions 
• Exhibit 123: 3D Bioprinting Solutions – Overview
• Exhibit 124: 3D Bioprinting Solutions – Product / Service
• Exhibit 125: 3D Bioprinting Solutions – Key offerings

• 12.4 3D Systems Corp. 
• Exhibit 126: 3D Systems Corp. – Overview
• Exhibit 127: 3D Systems Corp. – Business segments
• Exhibit 128: 3D Systems Corp. – Key news
• Exhibit 129: 3D Systems Corp. – Key offerings
• Exhibit 130: 3D Systems Corp. – Segment focus

• 12.5 Advanced Solutions Inc. 
• Exhibit 131: Advanced Solutions Inc. – Overview
• Exhibit 132: Advanced Solutions Inc. – Product / Service
• Exhibit 133: Advanced Solutions Inc. – Key offerings

• 12.6 Aspect Biosystems Ltd. 
• Exhibit 134: Aspect Biosystems Ltd. – Overview
• Exhibit 135: Aspect Biosystems Ltd. – Product / Service
• Exhibit 136: Aspect Biosystems Ltd. – Key offerings

• 12.7 BICO Group AB 
• Exhibit 137: BICO Group AB – Overview
• Exhibit 138: BICO Group AB – Business segments
• Exhibit 139: BICO Group AB – Key offerings
• Exhibit 140: BICO Group AB – Segment focus

• 12.8 CollPlant Biotechnologies Ltd. 
• Exhibit 141: CollPlant Biotechnologies Ltd. – Overview
• Exhibit 142: CollPlant Biotechnologies Ltd. – Product / Service
• Exhibit 143: CollPlant Biotechnologies Ltd. – Key offerings

• 12.9 Cyfuse Biomedical K.K. 
• Exhibit 144: Cyfuse Biomedical K.K. – Overview
• Exhibit 145: Cyfuse Biomedical K.K. – Product / Service
• Exhibit 146: Cyfuse Biomedical K.K. – Key offerings

• 12.10 Desktop Metal Inc. 
• Exhibit 147: Desktop Metal Inc. – Overview
• Exhibit 148: Desktop Metal Inc. – Business segments
• Exhibit 149: Desktop Metal Inc. – Key news
• Exhibit 150: Desktop Metal Inc. – Key offerings
• Exhibit 151: Desktop Metal Inc. – Segment focus

• 12.11 GE Healthcare Technologies Inc. 
• Exhibit 152: GE Healthcare Technologies Inc. – Overview
• Exhibit 153: GE Healthcare Technologies Inc. – Business segments
• Exhibit 154: GE Healthcare Technologies Inc. – Key offerings
• Exhibit 155: GE Healthcare Technologies Inc. – Segment focus

• 12.12 Hangzhou Jienuofei Biotechnology Co. Ltd.
• Exhibit 156: Hangzhou Jienuofei Biotechnology Co. Ltd. – Overview
• Exhibit 157: Hangzhou Jienuofei Biotechnology Co. Ltd. – Product / Service
• Exhibit 158: Hangzhou Jienuofei Biotechnology Co. Ltd. – Key offerings

• 12.13 Inventia Life Science Pty Ltd. 
• Exhibit 159: Inventia Life Science Pty Ltd. – Overview
• Exhibit 160: Inventia Life Science Pty Ltd. – Product / Service
• Exhibit 161: Inventia Life Science Pty Ltd. – Key offerings

• 12.14 Organovo Holdings Inc. 
• Exhibit 162: Organovo Holdings Inc. – Overview
• Exhibit 163: Organovo Holdings Inc. – Business segments
• Exhibit 164: Organovo Holdings Inc. – Key offerings
• Exhibit 165: Organovo Holdings Inc. – Segment focus

• 12.15 Poietis 
• Exhibit 166: Poietis – Overview
• Exhibit 167: Poietis – Product / Service
• Exhibit 168: Poietis – Key offerings

• 12.16 regenHU Ltd. 
• Exhibit 169: regenHU Ltd. – Overview
• Exhibit 170: regenHU Ltd. – Product / Service
• Exhibit 171: regenHU Ltd. – Key offerings

• 12.17 ROKIT Healthcare Inc. 
• Exhibit 172: ROKIT Healthcare Inc. – Overview
• Exhibit 173: ROKIT Healthcare Inc. – Product / Service
• Exhibit 174: ROKIT Healthcare Inc. – Key offerings

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 175: Inclusions checklist
• Exhibit 176: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 177: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 178: Research methodology
• Exhibit 179: Validation techniques employed for market sizing
• Exhibit 180: Information sources

• 13.5 List of abbreviations 
• Exhibit 181: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]

Website: www.technavio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-bioprinting-market-size-to-grow-by-usd-2-015-81-million-from-2022-to-2027advancements-in-3d-bioprinting-technology-to-drive-the-market—technavio-301889463.html

SOURCE Technavio

Featured image: Megapixl © Vladimircaribb

Disclaimer